161 related articles for article (PubMed ID: 18202977)
1. Evaluation of 'out-of-specification' CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products.
Braakman E; Schuurhuis GJ; Preijers FW; Voermans C; Theunissen K; van Riet I; Fibbe WE; Slaper-Cortenbach I
Cytotherapy; 2008; 10(1):83-9. PubMed ID: 18202977
[TBL] [Abstract][Full Text] [Related]
2. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
[TBL] [Abstract][Full Text] [Related]
3. Red blood cell depletion and enrichment of CD34+ hematopoietic progenitor cells from human umbilical cord blood using soybean agglutinin and CD34 immunoselection.
Nagler A; Peacock M; Tantoco M; Lamons D; Okarma TB; Okrongly DA
Exp Hematol; 1994 Nov; 22(12):1134-40. PubMed ID: 7523166
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.
Poloucková A; Vodvárková A; Kobylka P; Hrubá A; Gasová Z; Marinov I; Fales I; Sedlácek P; Kozák T; Starý J
Neoplasma; 2001; 48(5):374-81. PubMed ID: 11845982
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous immunomagnetic CD34+ cell selection and B-cell depletion in peripheral blood progenitor cell samples of patients suffering from B-cell non-Hodgkin's lymphoma.
Mohr M; Dalmis F; Hilgenfeld E; Oelmann E; Zühlsdorf M; Kratz-Albers K; Nolte A; Schmitmann C; Onaldi-Mohr D; Cassens U; Serve H; Sibrowski W; Kienast J; Berdel WE
Clin Cancer Res; 2001 Jan; 7(1):51-7. PubMed ID: 11205918
[TBL] [Abstract][Full Text] [Related]
6. Large scale purification of human blood CD34+ cells from cryopreserved peripheral blood stem cells, using a nylon-fiber syringe system and immunomagnetic microspheres.
Koizumi K; Nishio M; Endo T; Takashima H; Haseyama Y; Fujimoto K; Yamamoto S; Sato N; Ikebuchi K; Ikeda H; Koike T; Sawada K
Bone Marrow Transplant; 2000 Oct; 26(7):787-93. PubMed ID: 11042662
[TBL] [Abstract][Full Text] [Related]
7. The excessive numbers of total nucleated cells does not affect the performance of the CliniMACS.
Arpaci F; Cetin T; Ozet A; Oysul K; Pekel A; Ataergin S; Kuzhan O; Kömürcü S; Oztürk B
J Clin Apher; 2004; 19(4):197-201. PubMed ID: 15597344
[TBL] [Abstract][Full Text] [Related]
8. Blood progenitor cell separation from clinical leukapheresis product by magnetic nanoparticle binding and magnetophoresis.
Jing Y; Moore LR; Williams PS; Chalmers JJ; Farag SS; Bolwell B; Zborowski M
Biotechnol Bioeng; 2007 Apr; 96(6):1139-54. PubMed ID: 17009321
[TBL] [Abstract][Full Text] [Related]
9. HPC enumeration with the Sysmex XE-2100 can guide further flow cytometric CD34(+) measurements and timing of leukaphereses.
Oelschlaegel U; Bornhaeuser M; Thiede C; Ehninger G; Hoelig K
Cytotherapy; 2003; 5(5):414-9. PubMed ID: 14578103
[TBL] [Abstract][Full Text] [Related]
10. Determination of residual T- and B-cell content after immunomagnetic depletion: proposal for flow cytometric analysis and results from 103 separations.
Schumm M; Handgretinger R; Pfeiffer M; Feuchtinger T; Kuci S; Faul C; Vogel W; Bethge W; Lang P
Cytotherapy; 2006; 8(5):465-72. PubMed ID: 17050251
[TBL] [Abstract][Full Text] [Related]
11. Comparison of CD34+ bone marrow cells purified by immunomagnetic and immunoadsorption cell separation techniques.
Firat H; Giarratana MC; Kobari L; Poloni A; Bouchet S; Labopin M; Gorin NC; Douay L
Bone Marrow Transplant; 1998 May; 21(9):933-8. PubMed ID: 9613787
[TBL] [Abstract][Full Text] [Related]
12. In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression.
Villaron EM; Almeida J; Lopez-Holgado N; Sanchez-Guijo FM; Alberca M; Blanco B; Sanchez-Abarca LI; Lopez O; Perez-Simon JA; San Miguel JF; del Cañizo MC
Transfus Apher Sci; 2007 Oct; 37(2):145-56. PubMed ID: 17983836
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of the original content of CD34(+) cells for enrichment of hematopoietic progenitor cells from bone marrow harvests by the apheresis procedure.
Itoh T; Minegishi M; Kudo Y; Saito N; Takahashi H; Suzuki A; Narita A; Sato Y; Miura J; Inoue Y; Kameoka J; Suwabe N; Imaizumi M; Okuda M; Tsuchiya S
J Clin Apher; 2006 Oct; 21(3):176-80. PubMed ID: 16619225
[TBL] [Abstract][Full Text] [Related]
14. [Effect of immunomagnetic selection in purging autologous peripheral blood progenitor cell of breast cancer patients].
Han X; Shi Y; Zhang W
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):203-6. PubMed ID: 11953162
[TBL] [Abstract][Full Text] [Related]
15. Negative selection of hematopoietic progenitor cells by continuous magnetophoresis.
Jing Y; Moore LR; Schneider T; Williams PS; Chalmers JJ; Farag SS; Bolwell B; Zborowski M
Exp Hematol; 2007 Apr; 35(4):662-72. PubMed ID: 17379076
[TBL] [Abstract][Full Text] [Related]
16. Rapid and effective CD3 T-cell depletion with a magnetic cell sorting program to produce peripheral blood progenitor cell products for haploidentical transplantation in children and adults.
Dykes JH; Toporski J; Juliusson G; Békássy AN; Lenhoff S; Lindmark A; Scheding S
Transfusion; 2007 Nov; 47(11):2134-42. PubMed ID: 17958543
[TBL] [Abstract][Full Text] [Related]
17. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
[TBL] [Abstract][Full Text] [Related]
18. Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells.
Abrahamsen JF; Stamnesfet S; Liseth K; Hervig T; Bruserud O
Transfusion; 2005 Feb; 45(2):248-53. PubMed ID: 15660835
[TBL] [Abstract][Full Text] [Related]
19. Improving the efficiency of PBPC collection by pre-apheresis peripheral blood and mid-apheresis product measurements of CD34 cells.
Lane TA; Bashey A; Carrier E; Holman P; Castro J; Mullen M; Ward DM; Ada O; Ball ED
Cytotherapy; 2004; 6(4):318-27. PubMed ID: 16146884
[TBL] [Abstract][Full Text] [Related]
20. Automated CD34+ cell isolation of peripheral blood stem cell apheresis product.
Spohn G; Wiercinska E; Karpova D; Bunos M; Hümmer C; Wingenfeld E; Sorg N; Poppe C; Huppert V; Stuth J; Reck K; Essl M; Seifried E; Bönig H
Cytotherapy; 2015 Oct; 17(10):1465-71. PubMed ID: 25981397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
